First Tracks Biotherapeutics TRAX
NASDAQ TRAX
$46.56 -0.54 (-1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

First Tracks Biotherapeutics (TRAX) Payables (2024 - 2026)

Updated

First Tracks Biotherapeutics (TRAX) posted Payables of $3.95 million for Q3 2026, up 54.7% from the prior quarter.

Analysis

First Tracks Biotherapeutics (TRAX) Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, First Tracks Biotherapeutics' Payables came in at $3.11 million, down 17.8% from FY2024.

  • In prior years, First Tracks Biotherapeutics' Payables was $3.79 million in FY2024.
  • Quarterly Payables has run from a low of $2.55 million in Q2 2026 to a high of $7.5 million in Q1 2026 over five years.
  • According to Business Quant data, Payables for the three prior quarters was $2.55 million (Q2 2026), $7.5 million (Q1 2026) and $3.11 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 5.79 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 18.17 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 34.43 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 7.17 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -24.05 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 2.95 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 934.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 4.07 Bn
10 First Tracks Biotherapeutics 1.66 Bn 740.14 Mn - 3.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.95 Mn
Jun 30, 2026 2.55 Mn
Mar 31, 2026 7.50 Mn
Dec 31, 2025 3.11 Mn
Dec 31, 2024 3.79 Mn
API Access

First Tracks Biotherapeutics Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=TRAX&period=max&api_key=YOUR_API_KEY